216 related articles for article (PubMed ID: 29194002)
1. Auranofin, a thioredoxin reductase inhibitor, causes platelet death through calcium overload.
Harper MT
Platelets; 2019; 30(1):98-104. PubMed ID: 29194002
[TBL] [Abstract][Full Text] [Related]
2. Selective inhibition of endogenous antioxidants with Auranofin causes mitochondrial oxidative stress which can be countered by selenium supplementation.
Radenkovic F; Holland O; Vanderlelie JJ; Perkins AV
Biochem Pharmacol; 2017 Dec; 146():42-52. PubMed ID: 28947276
[TBL] [Abstract][Full Text] [Related]
3. Potential Anticancer Activity of Auranofin.
Onodera T; Momose I; Kawada M
Chem Pharm Bull (Tokyo); 2019; 67(3):186-191. PubMed ID: 30827998
[TBL] [Abstract][Full Text] [Related]
4. Auranofin, an inhibitor of thioredoxin reductase, induces apoptosis in hepatocellular carcinoma Hep3B cells by generation of reactive oxygen species.
Hwang-Bo H; Jeong JW; Han MH; Park C; Hong SH; Kim GY; Moon SK; Cheong J; Kim WJ; Yoo YH; Choi YH
Gen Physiol Biophys; 2017 Apr; 36(2):117-128. PubMed ID: 28218611
[TBL] [Abstract][Full Text] [Related]
5. The thioredoxin reductase inhibitor auranofin triggers apoptosis through a Bax/Bak-dependent process that involves peroxiredoxin 3 oxidation.
Cox AG; Brown KK; Arner ES; Hampton MB
Biochem Pharmacol; 2008 Oct; 76(9):1097-109. PubMed ID: 18789312
[TBL] [Abstract][Full Text] [Related]
6. Auranofin radiosensitizes tumor cells through targeting thioredoxin reductase and resulting overproduction of reactive oxygen species.
Wang H; Bouzakoura S; de Mey S; Jiang H; Law K; Dufait I; Corbet C; Verovski V; Gevaert T; Feron O; Van den Berge D; Storme G; De Ridder M
Oncotarget; 2017 May; 8(22):35728-35742. PubMed ID: 28415723
[TBL] [Abstract][Full Text] [Related]
7. Cross-talk between two antioxidants, thioredoxin reductase and heme oxygenase-1, and therapeutic implications for multiple myeloma.
Raninga PV; Di Trapani G; Vuckovic S; Tonissen KF
Redox Biol; 2016 Aug; 8():175-85. PubMed ID: 26795735
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of thioredoxin reductase (TrxR) triggers oxidative stress-induced apoptosis in filarial nematode Setaria cervi channelized through ASK-1-p38 mediated caspase activation.
Joardar N; Sen A; Rath J; Babu SPS
Mol Biochem Parasitol; 2021 Mar; 242():111364. PubMed ID: 33639230
[TBL] [Abstract][Full Text] [Related]
9. Targeting redox homeostasis in rhabdomyosarcoma cells: GSH-depleting agents enhance auranofin-induced cell death.
Habermann KJ; Grünewald L; van Wijk S; Fulda S
Cell Death Dis; 2017 Oct; 8(10):e3067. PubMed ID: 28981107
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of thioredoxin reductase by auranofin induces apoptosis in adriamycin-resistant human K562 chronic myeloid leukemia cells.
Liu JJ; Liu Q; Wei HL; Yi J; Zhao HS; Gao LP
Pharmazie; 2011 Jun; 66(6):440-4. PubMed ID: 21699084
[TBL] [Abstract][Full Text] [Related]
11. Dual targeting of the thioredoxin and glutathione antioxidant systems in malignant B cells: a novel synergistic therapeutic approach.
Kiebala M; Skalska J; Casulo C; Brookes PS; Peterson DR; Hilchey SP; Dai Y; Grant S; Maggirwar SB; Bernstein SH
Exp Hematol; 2015 Feb; 43(2):89-99. PubMed ID: 25448488
[TBL] [Abstract][Full Text] [Related]
12. Thioredoxin reductase inhibition reduces relaxation by increasing oxidative stress and s-nitrosylation in mouse aorta.
Choi H; Tostes RC; Webb RC
J Cardiovasc Pharmacol; 2011 Nov; 58(5):522-7. PubMed ID: 21795991
[TBL] [Abstract][Full Text] [Related]
13. Sugar-Modified Analogs of Auranofin Are Potent Inhibitors of the Gastric Pathogen
Epstein TD; Wu B; Moulton KD; Yan M; Dube DH
ACS Infect Dis; 2019 Oct; 5(10):1682-1687. PubMed ID: 31487153
[No Abstract] [Full Text] [Related]
14. [Potential Anticancer Activity of Auranofin].
Momose I; Onodera T; Kawada M
Yakugaku Zasshi; 2021; 141(3):315-321. PubMed ID: 33642497
[TBL] [Abstract][Full Text] [Related]
15. Thioredoxin reductase inhibitor auranofin prevents membrane transport of diphtheria toxin into the cytosol and protects human cells from intoxication.
Schnell L; Dmochewitz-Kück L; Feigl P; Montecucco C; Barth H
Toxicon; 2016 Jun; 116():23-8. PubMed ID: 25911959
[TBL] [Abstract][Full Text] [Related]
16. Differential redox sensitivity of cathepsin B and L holds the key to autophagy-apoptosis interplay after Thioredoxin reductase inhibition in nutritionally stressed SH-SY5Y cells.
Nagakannan P; Eftekharpour E
Free Radic Biol Med; 2017 Jul; 108():819-831. PubMed ID: 28478025
[TBL] [Abstract][Full Text] [Related]
17. Cancer cell death induced by phosphine gold(I) compounds targeting thioredoxin reductase.
Gandin V; Fernandes AP; Rigobello MP; Dani B; Sorrentino F; Tisato F; Björnstedt M; Bindoli A; Sturaro A; Rella R; Marzano C
Biochem Pharmacol; 2010 Jan; 79(2):90-101. PubMed ID: 19665452
[TBL] [Abstract][Full Text] [Related]
18. Sublethal concentrations of diverse gold compounds inhibit mammalian cytosolic thioredoxin reductase (TrxR1).
Omata Y; Folan M; Shaw M; Messer RL; Lockwood PE; Hobbs D; Bouillaguet S; Sano H; Lewis JB; Wataha JC
Toxicol In Vitro; 2006 Sep; 20(6):882-90. PubMed ID: 16510263
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic cooperation between auranofin, a thioredoxin reductase inhibitor and anti-PD-L1 antibody for treatment of triple-negative breast cancer.
Raninga PV; Lee AC; Sinha D; Shih YY; Mittal D; Makhale A; Bain AL; Nanayakarra D; Tonissen KF; Kalimutho M; Khanna KK
Int J Cancer; 2020 Jan; 146(1):123-136. PubMed ID: 31090219
[TBL] [Abstract][Full Text] [Related]
20. ATM inhibition enhances Auranofin-induced oxidative stress and cell death in lung cell lines.
Ehrenfeld V; Heusel JR; Fulda S; van Wijk SJL
PLoS One; 2020; 15(12):e0244060. PubMed ID: 33338048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]